Terms: = Skin cancer AND KDR, VEGFR2, 3791, ENSG00000128052, P35968, VEGFR, CD309, FLK1 AND Prognosis
34 results:
1. VEGF/vegfr axis and its signaling in melanoma: Current knowledge toward therapeutic targeting agents and future perspectives.
Malekan M; Haass NK; Rokni GR; Gholizadeh N; Ebrahimzadeh MA; Kazeminejad A
Life Sci; 2024 May; 345():122563. PubMed ID: 38508233
[TBL] [Abstract] [Full Text] [Related]
2. Genetic Alterations of Melanoma Brain Metastases: A Systematic Review and Meta-Analysis.
Pala L; Bagnardi V; Tettamanzi F; Barberis M; Mazzarol G; Casali C; De Pas T; Pennacchioli E; Coppola S; Baldini F; Cocorocchio E; Ferrucci P; Patane' D; Saponara M; Queirolo P; Conforti F
Mol Diagn Ther; 2023 Jan; 27(1):5-13. PubMed ID: 36401787
[TBL] [Abstract] [Full Text] [Related]
3. The Overexpression of SLC25A13 Predicts Poor prognosis and Is Correlated with Immune Cell Infiltration in Patients with skin Cutaneous Melanoma.
Lv Y; Yuan CH; Han LY; Huang GR; Ju LC; Chen LH; Han HY; Zhang C; Zeng LH
Dis Markers; 2022; 2022():4091978. PubMed ID: 35607442
[TBL] [Abstract] [Full Text] [Related]
4. Novel treatment strategy for NRAS-mutated melanoma through a selective inhibitor of CD147/vegfr-2 interaction.
Landras A; Reger de Moura C; Villoutreix BO; Battistella M; Sadoux A; Dumaz N; Menashi S; Fernández-Recio J; Lebbé C; Mourah S
Oncogene; 2022 Apr; 41(15):2254-2264. PubMed ID: 35217792
[TBL] [Abstract] [Full Text] [Related]
5. IQ Motif-Containing GTPase-Activating Protein 2 Inhibits Breast cancer Angiogenesis by Suppressing vegfr2-AKT Signaling.
Kumar D; Patel SA; Khan R; Chawla S; Mohapatra N; Dixit M
Mol Cancer Res; 2022 Jan; 20(1):77-91. PubMed ID: 34615693
[TBL] [Abstract] [Full Text] [Related]
6. Identification ACTA2 and kdr as key proteins for prognosis of PD-1/PD-L1 blockade therapy in melanoma.
Wang Y; Li Z; Zhang Z; Chen X
Animal Model Exp Med; 2021 Jun; 4(2):138-150. PubMed ID: 34179721
[TBL] [Abstract] [Full Text] [Related]
7. Effective treatment of anlotinib in giant delayed pulmonary metastasis of osteosarcoma: a case report and literature review.
Long ZY; Lu Y; Li M; Chen G; Shi L; Xiao X; Bai Y; Zhang HM; Wang Z
Ann Palliat Med; 2021 Jun; 10(6):7073-7082. PubMed ID: 33548989
[TBL] [Abstract] [Full Text] [Related]
8. A novel variant of vegfr2 identified by a pan-cancer screening of recurrent somatic mutations in the catalytic domain of tyrosine kinase receptors enhances tumor growth and metastasis.
Grillo E; Corsini M; Ravelli C; di Somma M; Zammataro L; Monti E; Presta M; Mitola S
Cancer Lett; 2021 Jan; 496():84-92. PubMed ID: 33035615
[TBL] [Abstract] [Full Text] [Related]
9. Efficacy and safety of the vegfr2 inhibitor Apatinib for metastatic soft tissue sarcoma: Chinese cohort data from NCT03121846.
Liu X; Xu J; Li F; Liao Z; Ren Z; Zhu L; Shi Y; Zhao G; Bai X; Zhao J; Xing R; Teng S; Yang Y; Yang J
Biomed Pharmacother; 2020 Feb; 122():109587. PubMed ID: 31786466
[TBL] [Abstract] [Full Text] [Related]
10. Gene expression and promoter methylation of angiogenic and lymphangiogenic factors as prognostic markers in melanoma.
Monteiro AC; Muenzner JK; Andrade F; Rius FE; Ostalecki C; Geppert CI; Agaimy A; Hartmann A; Fujita A; Schneider-Stock R; Jasiulionis MG
Mol Oncol; 2019 Jun; 13(6):1433-1449. PubMed ID: 31069961
[TBL] [Abstract] [Full Text] [Related]
11. High expression of HMBOX1 contributes to poor prognosis of gastric cancer by promoting cell proliferation and migration.
Diao N; Li Y; Yang J; Jin C; Meng X; Jiao W; Feng J; Liu Z; Lu N
Biomed Pharmacother; 2019 Jul; 115():108867. PubMed ID: 31005794
[TBL] [Abstract] [Full Text] [Related]
12. Phase II trial of vegfr2 inhibitor apatinib for metastatic sarcoma: focus on efficacy and safety.
Liao Z; Li F; Zhang C; Zhu L; Shi Y; Zhao G; Bai X; Hassan S; Liu X; Li T; Xing P; Zhao J; Zhang J; Xing R; Teng S; Yang Y; Chen K; Yang J
Exp Mol Med; 2019 Feb; 51(3):1-11. PubMed ID: 30816108
[TBL] [Abstract] [Full Text] [Related]
13. Decreased expression of nemo-like kinase in melanoma is correlated with increased vascularity and metastasis.
Yang Y; Zhe H; Massoumi R; Ke H
Melanoma Res; 2019 Aug; 29(4):376-381. PubMed ID: 30778016
[TBL] [Abstract] [Full Text] [Related]
14. Correlation of Vascular Endothelial Growth Factor subtypes and their receptors with melanoma progression: A next-generation Tissue Microarray (ngTMA) automated analysis.
Seyed Jafari SM; Wiedmer C; Cazzaniga S; Frangež Ž; Shafighi M; Beltraminelli H; Weber B; Simon HU; Hunger RE
PLoS One; 2018; 13(11):e0207019. PubMed ID: 30408085
[TBL] [Abstract] [Full Text] [Related]
15. Apatinib treatment for KIT- and kdr-amplified angiosarcoma: a case report.
Yang L; Liu L; Han B; Han W; Zhao M
BMC Cancer; 2018 May; 18(1):618. PubMed ID: 29855279
[TBL] [Abstract] [Full Text] [Related]
16. Successful treatment of advanced pancreatic liposarcoma with apatinib: A case report and literature review.
Han T; Luan Y; Xu Y; Yang X; Li J; Liu R; Li Q; Zheng Z
Cancer Biol Ther; 2017 Sep; 18(9):635-639. PubMed ID: 28678611
[TBL] [Abstract] [Full Text] [Related]
17. EMMPRIN/CD147 is an independent prognostic biomarker in cutaneous melanoma.
Caudron A; Battistella M; Feugeas JP; Pages C; Basset-Seguin N; Mazouz Dorval S; Funck Brentano E; Sadoux A; Podgorniak MP; Menashi S; Janin A; Lebbé C; Mourah S
Exp Dermatol; 2016 Aug; 25(8):618-22. PubMed ID: 27060463
[TBL] [Abstract] [Full Text] [Related]
18. Future perspectives in melanoma research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014.
Ascierto PA; Atkins M; Bifulco C; Botti G; Cochran A; Davies M; Demaria S; Dummer R; Ferrone S; Formenti S; Gajewski TF; Garbe C; Khleif S; Kiessling R; Lo R; Lorigan P; Arthur GM; Masucci G; Melero I; Mihm M; Palmieri G; Parmiani G; Puzanov I; Romero P; Schilling B; Seliger B; Stroncek D; Taube J; Tomei S; Zarour HM; Testori A; Wang E; Galon J; Ciliberto G; Mozzillo N; Marincola FM; Thurin M
J Transl Med; 2015 Nov; 13():374. PubMed ID: 26619946
[TBL] [Abstract] [Full Text] [Related]
19. Microvessel density and expression of vascular endothelial growth factor and its receptors in different subtypes of primary cutaneous B-cell lymphoma.
Wobser M; Siedel C; Kneitz H; Bröcker EB; Goebeler M; Houben R; Geissinger E
Acta Derm Venereol; 2013 Nov; 93(6):656-62. PubMed ID: 23624620
[TBL] [Abstract] [Full Text] [Related]
20. Phosphorylated pvegfr2/kdr receptor expression in uveal melanomas: relation with HIF2α and survival.
Giatromanolaki A; Sivridis E; Bechrakis NE; Willerding G; St Charitoudis G; Foerster MH; Gatter KC; Harris AL; Koukourakis MI
Clin Exp Metastasis; 2012 Jan; 29(1):11-7. PubMed ID: 21984395
[TBL] [Abstract] [Full Text] [Related]
[Next]
